Across TCGA pan-cancer cohorts, LELP1 Mutation is linked to patient survival in 3 of 34 cancer types, making it a survival-associated LELP1 data layer compared with 13 for mass-spec protein.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher LELP1 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated LELP1 expression acts as an unfavorable survival marker, although some lineages such as GBM show a favorable association.

LUAD, STAD, and GBM are the cancer types where LELP1 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	OS	Median	III,IV	0.057	0.680	<.001	21	view →
STAD	OS	Median	All	0.022	0.731	<.001	18	view →
GBM	DFS	Median	All	1.000	0.192	.036	2	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

Exploration

Same gene, other analysis: LELP1 tumor-vs-normal RNA expression · all LELP1 data types